...Mobidiag Ltd. , Espoo, Finland Business: Diagnostic Date announced: 2016-07-14 Note: Mobidiag secured a EUR15 million...
...$16.6 million), seven-year loan from the European Investment Bank. The loan will comprise three tranches. Mobidiag...

...pylori and resistance to clarithromycin from stool samples. Amplidiag H. pylori+ClariR is a qPCR-based diagnostic. Mobidiag Ltd....

...of the hypervirulence-associated 027 ribotype from stool samples. The qPCR-based diagnostic is available in Europe. Mobidiag Ltd....

...to screen for gastroenteritis-causing bacteria from stool samples. The PCR-based diagnostic has CE Mark approval. Mobidiag Ltd....

...in a stock deal, with Genewave and Amplidiag becoming subsidiaries of Mobidiag. The newco combines Mobidiag's...
...The combined company is headquartered in Helsinki and has a "center of excellence" in Paris. Mobidiag...
...company also received public funding from Finnish agencies Tekes and Finnvera and from the EU. Mobidiag's...

...has CE mark approval in Europe to diagnose sepsis. Data were published in The Lancet. Mobidiag Ltd....

...when it expects to launch the microarray assay, which is already marketed for research purposes. Mobidiag Ltd....

...that were not identified by marketed PCR diagnostics. The test is marketed for research purposes. Mobidiag Ltd....

...company's StripArray platform, which can analyze up to 96 samples, testing for 64 bacteria, simultaneously. Mobidiag Ltd....

...identification of sepsis-causing pathogens in blood cultures. The in vitro assay has CE Mark approval. Mobidiag Ltd....